Ptc Therapeutics Stock Price on November 7, 2024
| PTCT Stock | USD 43.23 0.34 0.79% |
Below is the normalized historical share price chart for PTC Therapeutics extending back to June 20, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of PTC Therapeutics stands at 43.23, as last reported on the 25th of November, with the highest price reaching 44.10 and the lowest price hitting 42.74 during the day.
If you're considering investing in PTC Stock, it is important to understand the factors that can impact its price. PTC Therapeutics appears to be very steady, given 3 months investment horizon. PTC Therapeutics retains Efficiency (Sharpe Ratio) of 0.11, which implies the firm had a 0.11% return per unit of risk over the last 3 months. We have found thirty technical indicators for PTC Therapeutics, which you can use to evaluate the volatility of the company. Please evaluate PTC Therapeutics' market risk adjusted performance of 0.2877, and Semi Deviation of 2.43 to confirm if our risk estimates are consistent with your expectations.
At this time, PTC Therapeutics' Other Stockholder Equity is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 137.8 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 49.7 M in 2024. . Price To Sales Ratio is likely to drop to 2.09 in 2024. Price Earnings Ratio is likely to drop to -3.46 in 2024. PTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of June 2013 | 200 Day MA 33.6054 | 50 Day MA 39.298 | Beta 0.628 |
PTC |
Sharpe Ratio = 0.1069
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PTCT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.5 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average PTC Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PTC Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.7 K | Enterprise Value Ebitda (10.22) | Price Sales 3.7018 | Shares Float 61 M | Wall Street Target Price 45 |
PTC Therapeutics Main Headline on 7th of November 2024
PTC Therapeutics Q3 Earnings Taking a Look at Key Metrics Ve... by finance.yahoo.com
The headline numbers for PTC Therapeutics give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
PTC Therapeutics Valuation on November 7, 2024
It is possible to determine the worth of PTC Therapeutics on a given historical date. On November 7, 2024 PTC was worth 43.33 at the beginning of the trading date compared to the closed value of 42.96. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of PTC Therapeutics stock. Still, in general, we apply an absolute valuation method to find PTC Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of PTC Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against PTC Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 42.49 | 43.27 | 41.70 | 43.18 | 1,007,928 | |
11/07/2024 | 43.33 | 44.56 | 42.82 | 42.96 | 724,672 |
| 45.64 | 46.55 | 43.64 | 44.28 | 1,019,355 |
| Backtest PTC Therapeutics | | | PTC Therapeutics History | | | PTC Therapeutics Valuation | Previous | Next |
PTC Therapeutics Trading Date Momentum on November 7, 2024
| On November 08 2024 PTC Therapeutics was traded for 44.28 at the closing time. The top price for the day was 46.55 and the lowest listed price was 43.64 . The trading volume for the day was 1 M. The trading history from November 8, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 3.07% . The trading delta at closing time against the current closing price is 8.89% . |
PTC Therapeutics Fundamentals Correlations and Trends
By evaluating PTC Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among PTC Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PTC financial account trend analysis is a perfect complement when working with valuation or volatility modules.About PTC Therapeutics Stock history
PTC Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PTC is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in PTC Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing PTC Therapeutics stock prices may prove useful in developing a viable investing in PTC Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 74.8 M | 49.7 M | |
| Net Loss | -503.1 M | -478 M |
PTC Therapeutics Quarterly Net Working Capital |
|
PTC Therapeutics Stock Technical Analysis
PTC Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
PTC Therapeutics Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
PTC Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
PTC Therapeutics November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how PTC Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PTC Therapeutics shares will generate the highest return on investment. By undertsting and applying PTC Therapeutics stock market strength indicators, traders can identify PTC Therapeutics entry and exit signals to maximize returns
PTC Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for PTC Therapeutics' price direction in advance. Along with the technical and fundamental analysis of PTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of PTC to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1069 | |||
| Jensen Alpha | 0.2471 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.1126 | |||
| Treynor Ratio | 0.2777 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for PTC Stock Analysis
When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.